Worldwide Obesity and Weight Loss Treatment to Reach $9 Billion by 2010

New York, September 7, 2006 — With surgical interventions already skyrocketing as a means to fight obesity, the overall global obesity treatment market is expected to rapidly advance to upwards of $9 billion by 2010.

In 2005 alone, surgical interventions accounted for 68.9% of revenues, according to Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment, a new study from Kalorama Information. As the rates of worldwide obesity continue to climb over the next four years, surgical interventions are expected to increase substantially, accounting for 82.5% of the market.

Prescription and over-the-counter anti-obesity and weight loss pharmaceuticals—two categories which complete the obesity management market—pale in comparison in market share and revenues, primarily due to competitive pressures from the surgical segment. These pharmaceutical segments also struggle with fallout from the failure of breakthrough anti-obesity drugs and the inability of current drugs to produce major weight loss for the majority of patients.

“A major reason for the difficulty in developing anti-obesity drugs, and the minimal efficacy of those that have been developed, is that the condition is exceptionally complex, involving many poorly understood pathways,” acknowledges Mary Anne Crandall, the report’s author. “In this report we not only look at the rising incidence of global obesity, but at the sociological, environmental, genetic, and biological factors that are being studied as indicators for the disease. We also consider the healthcare and economic implications that the worldwide obesity epidemic is bringing about, as the costs to society are increasing at a rapid rate as well.”

Obesity: The Worldwide Market for Pharmaceutical and Surgical Treatment details the various categories of the obesity and weight loss markets; describes the worldwide market for prescription and over-the-counter anti-obesity and weight loss pharmaceuticals and surgical interventions; and identifies major market factors that may help to shape the worldwide market for obesity and weight loss management in the future. The report’s comprehensive introduction also provides a thorough analysis of the nature of obesity as a disease. It can be purchased directly from Kalorama Information by clicking:

http://www.bioportfolio.com/cgi-bin/acatalog/Obesity_-_The_Worldwide_Market_for_Pharmaceutical_and_Surgical_Treatment.html

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent market research for the life sciences. To view their catalogue go to:

http://www.bioportfolio.com/cgi-bin/acatalog/Kalorama.html